Skip to main content
TipRanks
Go Ultimate75% OFF

Meir Jakobsohn Insider Profile

4 Followers

Meir Jakobsohn, Director at Knight Therapeutics, holds 10.42M shares in Knight Therapeutics (Ticker: KHTRF). Most recently, Meir Jakobsohn Sold 27,600 shares of Knight Therapeutics on Jun 06, 2018 for an estimated value of $221.58K.

Meir Jakobsohn's Trading History

KHTRF
Knight Therapeutics
Jun 06, 2018DirectorInformative Sell221.58K$87.05M
KHTRF
Insider Shares: 10.42M (729.94%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Jun 06, 2018Informative SellC$221.58K27,600C$8.03+10.60%―
Jun 05, 2018Informative SellC$108.00K13,400C$8.06+10.60%―
Jun 02, 2018Informative SellC$152.94K19,000C$8.05+10.60%―
Jun 01, 2018Informative SellC$212.04K26,200C$8.09+10.60%―
May 31, 2018Informative SellC$40.50K5,000C$8.10+10.30%―

You May Also Like

Meir Jakobsohn insider profile FAQ

What is the percentage of profitable transactions made by Meir Jakobsohn?
The percentage of profitable transactions made by Meir Jakobsohn is 100%.
What is the average return per transaction made by Meir Jakobsohn?
The average return per transaction made by Meir Jakobsohn is 12.40%.
What stocks does Meir Jakobsohn hold?
Meir Jakobsohn holds: KHTRF stocks.
What was Meir Jakobsohn’s latest transaction?
Meir Jakobsohn’s latest transaction was an Informative Sell of $221.58K.
What was Meir Jakobsohn's most profitable transaction?
Meir Jakobsohn’s most profitable transaction was an Informative Buy of KHTRF stock on June 21, 2016. The return on the trade was 20.00%.
What is Meir Jakobsohn's role in Knight Therapeutics?
Meir Jakobsohn's role in Knight Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.